Buspirone for Comorbid Anxiety in Autism

References (25)

1. Maenner MJ, Shaw KA, Bakian AV, et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2018. MMWR Surveill Summ. 2021;70(11):1–16. PubMed CrossRef
2. DeFilippis M. Depression in children and adolescents with autism spectrum disorder. Children (Basel). 2018;5(9):112. PubMed CrossRef
3. van Steensel FJA, Bögels SM, Perrin S. Anxiety disorders in children and adolescents with autistic spectrum disorders: a meta-analysis. Clin Child Fam Psychol Rev. 2011;14(3):302–317. PubMed CrossRef
4. Zahid S, Upthegrove R. Suicidality in autistic spectrum disorders. Crisis. 2017;38(4):237–246. PubMed CrossRef
5. Lecavalier L, Wood JJ, Halladay AK, et al. Measuring anxiety as a treatment endpoint in youth with autism spectrum disorder. J Autism Dev Disord. 2014;44(5):1128–1143. PubMed CrossRef
6. Wendt FR, Pathak GA, Tylee DS, et al. Heterogeneity and polygenicity in psychiatric disorders: a genome-wide perspective. Chronic Stress (Thousand Oaks). 2020;4:2470547020924844. PubMed CrossRef
7. Rosen TE, Mazefsky CA, Vasa RA, et al. Co-occurring psychiatric conditions in autism spectrum disorder. Int Rev Psychiatry. 2018;30(1):40–61. PubMed CrossRef
8. Williams K, Brignell A, Randall M, et al. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database Syst Rev. 2013;(8). CrossRef
9. Johnson JG, Harris ES, Spitzer RL, et al. The Patient Health Questionnaire for Adolescents: validation of an instrument for the assessment of mental disorders among adolescent primary care patients. J Adolesc Health. 2002;30(3):196–204. PubMed CrossRef
10. Birmaher B, Khetarpal S, Brent D, et al. The Screen for Child Anxiety Related Emotional Disorders (SCARED): scale construction and psychometric characteristics. J Am Acad Child Adolesc Psychiatry. 1997;36(4):545–553. PubMed CrossRef
11. Ji N, Findling RL. An update on pharmacotherapy for autism spectrum disorder in children and adolescents. Curr Opin Psychiatry. 2015;28(2):91–101. PubMed CrossRef
12. Loane C, Politis M. Buspirone: what is it all about? Brain Res. 2012;1461:111–118. PubMed CrossRef
13. Howland RH. Buspirone: back to the future. J Psychosoc Nurs Ment Health Serv. 2015;53(11):21–24. PubMed CrossRef
14. Edwards DJ, Chugani DC, Chugani HT, et al. Pharmacokinetics of buspirone in autistic children. J Clin Pharmacol. 2006;46(5):508–514. PubMed CrossRef
15. Luft MJ, Lamy M, DelBello MP, et al. Antidepressant-induced activation in children and adolescents: risk, recognition and management. Curr Probl Pediatr Adolesc Health Care. 2018;48(2):50–62. PubMed CrossRef
16. Lane RM. SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment. J Psychopharmacol. 1998;12(2):192–214. PubMed CrossRef
17. Strawn JR, Mills JA, Cornwall GJ, et al. Buspirone in children and adolescents with anxiety: a review and Bayesian analysis of abandoned randomized controlled trials. J Child Adolesc Psychopharmacol. 2018;28(1):2–9. PubMed CrossRef
18. Buitelaar JK, van der Gaag RJ, van der Hoeven J. Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: results of an open-label study. J Clin Psychiatry. 1998;59(2):56–59. PubMed CrossRef
19. Ceranoglu TA, Wozniak J, Fried R, et al. A retrospective chart review of buspirone for the treatment of anxiety in psychiatrically referred youth with high-functioning autism spectrum disorder. J Child Adolesc Psychopharmacol. 2019;29(1):28–33. PubMed CrossRef
20. Ghanizadeh A, Ayoobzadehshirazi A. A randomized double-blind placebo-controlled clinical trial of adjuvant buspirone for irritability in autism. Pediatr Neurol. 2015;52(1):77–81. PubMed CrossRef
21. Chugani DC, Chugani HT, Wiznitzer M, et al; Autism Center of Excellence Network. Efficacy of low-dose buspirone for restricted and repetitive behavior in young children with autism spectrum disorder: a randomized trial. J Pediatr. 2016;170:45–53.e4. PubMed CrossRef
22. Hollander E, Phillips A, Chaplin W, et al. A placebo-controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology. 2005;30(3):582–589. PubMed CrossRef
23. Kirino E. Efficacy and safety of aripiprazole in child and adolescent patients. Eur Child Adolesc Psychiatry. 2012;21(7):361–368. PubMed CrossRef
24. Banas K, Sawchuk B. Clonidine as a treatment of behavioral disturbances in autism spectrum disorder: a systematic literature review. J Can Acad Child Adolesc Psychiatry. 2020;29(2):110–120. PubMed
25. Narayanan A, White CA, Saklayen S, et al. Effect of propranolol on functional connectivity in autism spectrum disorder: a pilot study. Brain Imaging Behav. 2010;4(2):189–197. PubMed CrossRef